Vycor Medical Inc (VYCO): R&D Expense
$10.0K
Year ended 2025-12-31
-17.9%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.0K | -35.0% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $15.3K | -32.1% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $22.6K | n/a | 2025-04-15, From 2023-01-01 |
| No annual figure between 2021-12-31 and 2023-12-31. | |||
| 2021-12-31 | $15.2K | n/a | 2023-04-14, From 2021-01-01 |
| 2020-12-31 | $0 | n/a | 2021-03-31, From 2020-01-01 |
| 2019-12-31 | $0 | n/a | 2021-03-31, From 2019-01-01 |
| No annual figure between 2017-12-31 and 2019-12-31. | |||
| 2017-12-31 | $3.0K | -36.4% | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | $4.7K | -93.4% | 2018-03-30, From 2016-01-01 |
| 2015-12-31 | $71.5K | +3.5% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $69.1K | +29.3% | 2015-03-31, From 2014-01-01 |
| 2013-12-31 | $53.5K | -57.6% | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | $126.0K | +9.0% | 2014-04-07, From 2012-01-01 |
| 2011-12-31 | $115.7K | +660.6% | 2013-04-01, From 2011-01-01 |
| 2010-12-31 | $15.2K | n/a | 2012-03-30, From 2010-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Vycor Medical Inc (VYCO) | 2025-12-31 | $10.0K | -35.0% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $23.94M | -11.5% |
| Femasys Inc (FEMY) | 2025-12-31 | $7.58M | -7.8% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $484.9K | +64.7% |
| SeaStar Medical Holding Corp (ICU) | 2025-12-31 | $7.52M | -17.4% |
| OSR Health, Inc. (OSRH) | 2025-12-31 | $318.4K | +97.6% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $1.42M | -10.6% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $6.27M | +4.0% |
| IceCure Medical Ltd. (ICCM) | 2025-12-31 | $7.43M | +4.7% |
Compare VYCO, NONE., FEMY, USAQ side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗